We are committed to build a world-leading Inhalation medicines company
Home
Our Company
Who We Are
Our Leadership Team
Our Subject Matter Technical Experts
Our Science
Why Inhalation Therapy
Inhalation Therapies for Lung Diseases
Inhalation Therapies for Systemic Diseases
Pipeline
Partnering
Careers
News
Contact Us
Transpire Bio announces agreement with INTO for the development of three inhaled medicines
HOME
> Our Company > Transpire Bio announces agreement with INTO for the development of three inhaled medicines
Transpire Bio announces agreement with INTO for the development of three inhaled medicines
October 14, 2022
Nick Barto
Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment
October 10, 2022
Nick Barto
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
August 25, 2022
Nick Barto
